If approved, it would be the first injectable combination of a GLP-1 and an amylin analog on the market
Acknowledgements The authors thank all past and present members of the Schmitt laboratory for the many contributions over the years, and apologize to authors whose work could not be cited owing to space limitations
CrossRef Increasing Mortality in Korean Patients With Breast Cancer: High Mortality Rate in Elderly Breast Cancer Population Due to Suboptimal Treatment and Other Diseases Hyangsuk Choi, Hany Noh, Kwang-Min Kim, In-Jeong Cho, Seungtaek Lim, Airi Han Cancer Control.2021;[Epub] CrossRef Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma Hyeonkyeong Kim, Hyungju Kwon, Byung-In Moon JAMA OtolaryngologyHead & Neck Surgery.2021
Ozempic gets all the buzz but many medications are approved for weight loss by the FDA or prescribed off-label
The principle holds true here
(I)Core Mechanism of Action: As a long-acting amylin analog, it enhances satiety and suppresses hunger through central regulation while improving control over food cravings, particularly for sweet and fatty foods